Prestige Consumer Healthcare Inc. (NYSE:PBH) Stock Holdings Boosted by Principal Financial Group Inc.

Principal Financial Group Inc. raised its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 3.2% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 264,817 shares of the company's stock after acquiring an additional 8,291 shares during the period. Principal Financial Group Inc. owned approximately 0.53% of Prestige Consumer Healthcare worth $22,766,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in PBH. Meritage Portfolio Management lifted its stake in shares of Prestige Consumer Healthcare by 6.8% in the first quarter. Meritage Portfolio Management now owns 13,702 shares of the company's stock valued at $1,178,000 after purchasing an additional 876 shares during the period. KBC Group NV lifted its stake in shares of Prestige Consumer Healthcare by 7.4% in the first quarter. KBC Group NV now owns 2,199 shares of the company's stock valued at $189,000 after purchasing an additional 151 shares during the period. Bessemer Group Inc. lifted its stake in shares of Prestige Consumer Healthcare by 22.7% in the first quarter. Bessemer Group Inc. now owns 361,958 shares of the company's stock valued at $31,118,000 after purchasing an additional 66,908 shares during the period. Advisor Resource Council acquired a new stake in shares of Prestige Consumer Healthcare in the first quarter valued at about $2,232,000. Finally, Avior Wealth Management LLC lifted its stake in shares of Prestige Consumer Healthcare by 38.2% in the first quarter. Avior Wealth Management LLC now owns 11,824 shares of the company's stock valued at $1,017,000 after purchasing an additional 3,270 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Down 1.6%

Shares of NYSE PBH traded down $1.21 during midday trading on Friday, reaching $76.33. 507,395 shares of the stock were exchanged, compared to its average volume of 311,773. Prestige Consumer Healthcare Inc. has a 52-week low of $64.94 and a 52-week high of $90.04. The stock has a 50 day moving average price of $83.76 and a 200-day moving average price of $82.38. The company has a market capitalization of $3.77 billion, a P/E ratio of 17.79, a P/E/G ratio of 2.30 and a beta of 0.43. The company has a current ratio of 4.20, a quick ratio of 2.82 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. The firm had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. Prestige Consumer Healthcare's revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.02 earnings per share. Equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PBH has been the subject of several recent analyst reports. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, Prestige Consumer Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.